BECTON DICKINSON & CO·4

Nov 29, 5:24 PM ET

Hickey David 4

4 · BECTON DICKINSON & CO · Filed Nov 29, 2022

Insider Transaction Report

Form 4
Period: 2022-11-26
Hickey David
EVP & President, Life Sciences
Transactions
  • Award

    Common Stock

    2022-11-26+1,8165,147 total
  • Award

    Stock Appreciation Rights

    2022-11-26+10,97510,975 total
    Exercise: $238.06From: 2023-11-26Exp: 2032-11-26Common Stock (10,975 underlying)
  • Award

    Rights to Common Stock Under Deferred Compensation Plan

    2022-11-26+1,12512,100 total
    Exercise: $238.06Common Stock (1,125 underlying)
Footnotes (3)
  • [F1]Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
  • [F2]The stock appreciation rights vest in four annual installments beginning November 26, 2023.
  • [F3]The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES